Zydus Cadila has received approval to market Tadalafil tablets in the US market, from the US health regulator. It is used for treatment of erectile dysfunction and the signs and symptoms of benign prostatic hyperplasia.

As per the company, it has received tentative approval from the US Food and Drug Administration (USFDA) to market Tadalafil tablets USP in the strengths of 2.5 mg, 5 mg, 10 mg, and 20 mg.

Further, the product will be manufactured at the group’s formulations manufacturing facility at Moraiya, Ahmedabad.

Read EquityPandit’s Technical Analysis on Nifty Pharma Outlook for the Week